This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khan, A. Articles by Newman, L. A. Search for Related Content PubMed PubMed Citation Articles by Khan, A. Articles by Newman, L. A.

Comprehensive Axillary Evaluation in Neoadjuvant Chemotherapy Patients With Ultrasonography and Sentinel Lymph Node Biopsy

¹ Department of Surgery, Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109
² Department of Radiology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan 48109
³ Department of Pathology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan 48109
⁴ Department of Medical Oncology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan 48109

Correspondence: Address correspondence and reprint requests to: Lisa A. Newman, MD, MPH; E-mail: lanewman{at}umich.edu

Background: There is ongoing debate regarding the optimal sequence of sentinel lymph node (SLN) biopsy and neoadjuvant chemotherapy (CTX) for breast cancer. We report the accuracy of comprehensive pre–neoadjuvant CTX and post–neoadjuvant CTX axillary staging via ultrasound imaging, fine-needle aspiration (FNA) biopsy, and SLN biopsy.

Methods: From 2001 to 2004, 91 neoadjuvant CTX patients at the University of Michigan Comprehensive Cancer Center underwent axillary staging by ultrasonography, ultrasound-guided FNA biopsy, SLN biopsy, or a combination of these.

Results: Axillary staging was pathologically negative by pre–neoadjuvant CTX SLN biopsy in 53 cases (58%); these patients had no further axillary surgery. In 38 cases (42%), axillary metastases were confirmed at presentation by either ultrasound-guided FNA or SLN biopsy. These 38 patients underwent completion axillary lymph node dissection (ALND) after delivery of neoadjuvant CTX. Follow-up lymphatic mapping was attempted in 33 of these cases, and the SLN was identified in 32 (identification rate, 97%). One third of these cases were completely node negative on ALND. Residual metastatic disease was identified in 22 cases, and the SLN was falsely negative in 1 (4.5%).

Conclusions: Patients receiving neoadjuvant CTX can have accurate axillary nodal staging by ultrasound-guided FNA or SLN biopsy. In cases of documented axillary metastasis at presentation, repeat axillary staging with SLN biopsy can document the post–neoadjuvant CTX nodal status. This strategy optimizes pre–neoadjuvant CTX and post–neoadjuvant CTX staging information by distinguishing the patients who are node negative at presentation from those who have been downstaged to node negativity and offers the potential for avoiding unnecessary ALNDs in both of these patient subsets.

Key Words: Neoadjuvant chemotherapy • Breast cancer • Axilla • Ultrasound • Sentinel node

This article has been cited by other articles:

				B. J. Grube, C. J. Christy, D. Black, M. Martel, L. Harris, J. Weidhaas, M. P. DiGiovanna, G. Chung, M. M. Abu-Khalaf, K. D. Miller, et al. Breast Sentinel Lymph Node Dissection Before Preoperative Chemotherapy Arch Surg, July 1, 2008; 143(7): 692 - 700. [Abstract] [Full Text] [PDF]

				A. Jain, M. E. Haisfield-Wolfe, J. Lange, N. Ahuja, N. Khouri, T. Tsangaris, Z. Zhang, C. Balch, and L. K. Jacobs The Role of Ultrasound-Guided Fine-Needle Aspiration of Axillary Nodes in the Staging of Breast Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 462 - 471. [Abstract] [Full Text] [PDF]

				E. A. Newman, M. S. Sabel, A. V. Nees, A. Schott, K. M. Diehl, V. M. Cimmino, A. E. Chang, C. Kleer, D. F. Hayes, and L. A. Newman Sentinel Lymph Node Biopsy Performed After Neoadjuvant Chemotherapy is Accurate in Patients with Documented Node-Positive Breast Cancer at Presentation Ann. Surg. Oncol., October 1, 2007; 14(10): 2946 - 2952. [Abstract] [Full Text] [PDF]

				J. T. Davis, Y. M. Brill, S. Simmons, B. C. Sachleben, M. L. Cibull, P. McGrath, H. Wright, E. Romond, M. Hester, A. Moore, et al. Ultrasound-Guided Fine-Needle Aspiration of Clinically Negative Lymph Nodes Versus Sentinel Node Mapping in Patients at High Risk for Axillary Metastasis Ann. Surg. Oncol., December 1, 2006; 13(12): 1545 - 1552. [Abstract] [Full Text] [PDF]

				E. A. Newman, V. M. Cimmino, M. S. Sabel, K. M. Diehl, K. A. Frey, A. E. Chang, and L. A. Newman Lymphatic Mapping and Sentinel Lymph Node Biopsy for Patients With Local Recurrence After Breast-Conservation Therapy Ann. Surg. Oncol., January 1, 2006; 13(1): 52 - 57. [Abstract] [Full Text] [PDF]